Cost-effectiveness analysis of savolitinib for locally advanced or metastatic non-small-cell lung cancer with MET mutations

JIANG Yuan, GAO Zhenyu, WANG Meisa, SHI Guiling

Chinese Journal of Hospital Pharmacy ›› 2024, Vol. 44 ›› Issue (6) : 690-695.

PDF(980 KB)
PDF(980 KB)
Chinese Journal of Hospital Pharmacy ›› 2024, Vol. 44 ›› Issue (6) : 690-695. DOI: 10.13286/j.1001-5213.2024.06.12
Drug and Clinical

Cost-effectiveness analysis of savolitinib for locally advanced or metastatic non-small-cell lung cancer with MET mutations

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 44(6): 690-695 https://doi.org/10.13286/j.1001-5213.2024.06.12

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(980 KB)

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉